Catalyst Accumulated Other Comprehensive Income from 2010 to 2024

CPRX Stock  USD 21.97  0.14  0.63%   
Catalyst Pharmaceuticals Accumulated Other Comprehensive Income yearly trend continues to be fairly stable with very little volatility. Accumulated Other Comprehensive Income is likely to outpace its year average in 2024. Accumulated Other Comprehensive Income is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. View All Fundamentals
 
Accumulated Other Comprehensive Income  
First Reported
2004-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
71.4 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Catalyst Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catalyst Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 5 M, Other Operating Expenses of 327 M or Operating Income of 91.2 M, as well as many indicators such as Price To Sales Ratio of 4.26, Dividend Yield of 0.0 or PTB Ratio of 4.38. Catalyst financial statements analysis is a perfect complement when working with Catalyst Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Catalyst Pharmaceuticals Correlation against competitors.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.

Latest Catalyst Pharmaceuticals' Accumulated Other Comprehensive Income Growth Pattern

Below is the plot of the Accumulated Other Comprehensive Income of Catalyst Pharmaceuticals over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Catalyst Pharmaceuticals' Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Catalyst Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Accumulated Other Comprehensive Income10 Years Trend
Slightly volatile
   Accumulated Other Comprehensive Income   
       Timeline  

Catalyst Accumulated Other Comprehensive Income Regression Statistics

Arithmetic Mean(50,165)
Geometric Mean33,864
Coefficient Of Variation(129.95)
Mean Deviation56,544
Median(59,074)
Standard Deviation65,188
Sample Variance4.2B
Range190.5K
R-Value0.36
Mean Square Error4B
R-Squared0.13
Significance0.18
Slope5,277
Total Sum of Squares59.5B

Catalyst Accumulated Other Comprehensive Income History

202414.7 K
202314 K
202224 K
2021-148 K
202031.3 K
2019 9505.0
2018-20.2 K

About Catalyst Pharmaceuticals Financial Statements

Catalyst Pharmaceuticals investors use historical fundamental indicators, such as Catalyst Pharmaceuticals' Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Catalyst Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income14 K14.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Catalyst Stock Analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.